<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="
The source stated that Scientists in the center "Memorial Sloan Kettering" for cancer in New York They did research on a blood test called "Gallery" It uses a single swab to look for a signal from many types of cancer, including those that affect the breasts, lungs and kidneys.
Scientists found that the test He succeeded in discovering 35 cases of cancer, but, in contrast, 57 other people were misdiagnosed.
The research concluded that the test "Gallery" He carries "big promises" in discovery crabswhich is currently only discovered in advanced stages of the disease.
He added that "The results were good, but more scrutiny is needed".
She said "Daily Mail" that a test "Gallery" It is currently available by prescription for $949 per pack.
The results of the research come just one day after US President Joe Biden revealed plans to reduce deaths cancer in half, to 300,000 annually by 2042.
Biden revealed that he hopes to do so by allocating millions of dollars to developing blood tests of cancers.
“>
The source stated that Scientists At Memorial Sloan Kettering Cancer Center in New York They researched a blood test called “Gallery” that uses a single swab to look for a signal from many types of cancer, including those that affect the breasts, lungs and kidneys.
Scientists found that the test He succeeded in discovering 35 cases of cancer, but, in contrast, 57 other people were misdiagnosed.
The research concluded that the “Gallery” test holds “great promises” in discovering crabswhich is currently only discovered in advanced stages of the disease.
“The results were good, but more scrutiny is needed,” he added.
The Daily Mail said that a test “Gallery” is currently available by prescription for $949 a box.
The results of the research come just one day after US President Joe Biden revealed plans to reduce deaths cancer in half, to 300,000 annually by 2042.
Biden revealed that he hopes to do so by allocating millions of dollars to developing blood tests of cancers.